NCT07650877 Comparison of the Rhomboid Intercostal Block and Serratus Posterior Superior Intercostal Plane Block
| NCT ID | NCT07650877 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Pain, Postoperative |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-06-15 |
| Primary Completion | 2026-11-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2026-06-15 with a primary completion date of 2026-11-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Video-assisted thoracic surgery (VATS) is widely performed for the management of various thoracic pathologies and is generally associated with reduced surgical trauma compared with open thoracotomy. Nevertheless, patients may still experience considerable postoperative pain, which can adversely affect respiratory function, mobilization, and recovery. Various regional analgesic techniques have been incorporated into multimodal pain management strategies for VATS, including thoracic paravertebral block (TPVB), erector spinae plane block (ESPB), intercostal nerve block, serratus anterior plane block (SAPB), rhomboid intercostal block (RIB), and serratus posterior superior intercostal plane block (SPSIPB). Among these approaches, ultrasound-guided TPVB has traditionally been regarded as a reference regional analgesic technique. More recently, interfascial plane blocks have gained increasing attention because of their technical simplicity and favorable safety profile. RIB and SPSIPB are two novel interfascial plane blocks that may provide effective postoperative analgesia following thoracic surgery. The present study aims to compare the analgesic efficacy of RIB and SPSIPB in patients undergoing VATS and to evaluate their impact on postoperative pain outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing elective VATS * Patients aged 18-75 years * Patients with ASA (American Society of Anesthesiologists) class I-III * Patients who have given informed consent Exclusion Criteria: * Patients allergic to local anesthetics * Patients with bleeding disorders or those undergoing anticoagulant therapy * Pregnant and breastfeeding women * Patients with impaired consciousness, inability to communicate, or mental/cognitive impairment * Patients who refuse block application * Patients with infection in the area where the block will be applied
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07650877 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Pain, Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07650877 currently recruiting?
Yes, NCT07650877 is actively recruiting participants. Contact the research team at nilbavullu@gmail.com for enrollment information.
Where is the NCT07650877 trial being conducted?
This trial is being conducted at Çankaya, Turkey (Türkiye).
Who is sponsoring the NCT07650877 clinical trial?
NCT07650877 is sponsored by Ankara City Hospital Bilkent. The trial plans to enroll 90 participants.